Stock Comparison
ABT vs ZBH
Abbott Laboratories and Zimmer Biomet Holdings Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$163.94B
$18.01B
P/E (TTM)
26.4
24.1
Forward P/E
17.2
11.2
Price/Sales
3.6
2.1
Price/Book
3.2
1.4
EV/EBITDA
16.1
10.9
Dividend Yield
2.62%
1.06%
Profitability
Net Margin
13.90%
9.05%
Operating Margin
13.50%
19.70%
Return on Equity
12.30%
6.07%
Return on Assets
5.59%
4.10%
Growth (YoY)
Revenue Growth
7.80%
9.30%
Earnings Growth
-19.70%
34.10%
Price & Risk
Beta
0.6
0.5
52-Week High
$135.34
$107.16
52-Week Low
$81.97
$78.91
Analyst Target
$116.54
$98.70
Compare ABT and ZBH your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.